View Item 

Show simple item record

Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis
dc.contributor.authorYounes, Laurenten_US
dc.contributor.authorRatnanather, J. Tilaken_US
dc.contributor.authorBrown, Timothyen_US
dc.contributor.authorAylward, Elizabethen_US
dc.contributor.authorNopoulos, Pegen_US
dc.contributor.authorJohnson, Hansen_US
dc.contributor.authorMagnotta, Vincent A.en_US
dc.contributor.authorPaulsen, Jane S.en_US
dc.contributor.authorMargolis, Russell L.en_US
dc.contributor.authorAlbin, Roger L.en_US
dc.contributor.authorMiller, Michael I.en_US
dc.contributor.authorRoss, Christopher A.en_US
dc.date.accessioned2014-02-11T17:56:59Z
dc.date.available2015-04-16T14:24:20Zen_US
dc.date.issued2014-03en_US
dc.identifier.citationYounes, Laurent; Ratnanather, J. Tilak; Brown, Timothy; Aylward, Elizabeth; Nopoulos, Peg; Johnson, Hans; Magnotta, Vincent A.; Paulsen, Jane S.; Margolis, Russell L.; Albin, Roger L.; Miller, Michael I.; Ross, Christopher A. (2014). "Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis." Human Brain Mapping 35(3): 792-809.en_US
dc.identifier.issn1065-9471en_US
dc.identifier.issn1097-0193en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/102648
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherOxford University Pressen_US
dc.subject.otherStriatal Atrophyen_US
dc.subject.otherPallidus Atrophyen_US
dc.subject.otherDiffeomorphic Mappingen_US
dc.subject.otherSurface Registrationen_US
dc.subject.otherSurface‐Based Morphometryen_US
dc.titleRegionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelKinesiology and Sportsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/102648/1/hbm22214.pdf
dc.identifier.doi10.1002/hbm.22214en_US
dc.identifier.sourceHuman Brain Mappingen_US
dc.identifier.citedreferenceRosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, Greve D, Hevelone N, Hersch SM ( 2008 ): Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity. Brain 131: 1057 – 1068.en_US
dc.identifier.citedreferenceRanen NG, Stine OC, Abbott MH, Sherr M, Codori AM, Franz ML, Chao NI, Chung AS, Pleasant N, Callahan C, Kash LM, Ghaffari M, Chase GA, Kazazian HH, Brandt J, Folstein SE, Ross CA ( 1995 ): Anticipation and instability of IT‐15 (CAG)n repeats in parent‐offspring pairs with Huntington disease. Am J Hum Genet 57: 593 – 602.en_US
dc.identifier.citedreferenceRangarajan A, Chui H, Bookstein F ( 1997 ): The softassign procrustes matching algorithm. Springer. p 29 – 42.en_US
dc.identifier.citedreferenceReiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB ( 1988 ): Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85: 5733.en_US
dc.identifier.citedreferenceRichfield EK, Herkenham M ( 1994 ): Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol 36: 577 – 584.en_US
dc.identifier.citedreferenceRichfield EK, Maguire‐Zeiss KA, Vonkeman HE, Voorn P ( 1995 ): Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Ann Neurol 38: 852 – 861.en_US
dc.identifier.citedreferenceRoss CA, Tabrizi SJ ( 2011 ): Huntington's disease: From molecular pathogenesis to clinical treatment. Lancet Neurol 10: 83 – 98.en_US
dc.identifier.citedreferenceSapp E, Ge P, Aizawa H, Bird E, Penney J, Young AB, Vonsattel JP, DiFiglia M ( 1995 ): Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 64: 397 – 404.en_US
dc.identifier.citedreferenceSelemon L, Goldman‐Rakic P ( 1985 ): Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci 5: 776 – 794.en_US
dc.identifier.citedreferenceSotrel A, Williams RS, Kaufmann WE, Myers RH ( 1993 ): Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: A quantitative Golgi study. Neurology 43: 2088 – 2096.en_US
dc.identifier.citedreferenceSquitieri F, Cannella M, Simonelli M, Sassone J, Martino T, Venditti E, Ciammola A, Colonnese C, Frati L, Ciarmiello A ( 2009 ): Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease. CNS Neurosci Ther 15: 1 – 11.en_US
dc.identifier.citedreferenceSritharan A, Egan GF, Johnston L, Horne M, Bradshaw JL, Bohanna I, Asadi H, Cunnington R, Churchyard AJ, Chua P, Farrow M, Georgiou‐Karistianis N ( 2010 ): A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease. J Neurol Neurosurg Psychiatry 81: 257 – 262.en_US
dc.identifier.citedreferenceStoffers D, Sheldon S, Kuperman J, Goldstein J, Corey‐Bloom J, Aron A ( 2010 ): Contrasting gray and white matter changes in preclinical Huntington disease: An MRI study. Neurology 74: 1208.en_US
dc.identifier.citedreferenceTabrizi SJ, Langbehn DR, Leavitt BR, Roos RAC, Durr A, Craufurd D, and Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC ( 2009 ): Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK‐HD study: Cross‐sectional analysis of baseline data. Lancet Neurol 8: 791 – 801.en_US
dc.identifier.citedreferenceTabrizi SJ, Reilmann R, Roos RAC, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR, the TRACK‐HD investigators ( 2012 ): Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK‐HD study: Analysis of 24 month observational data. Lancet Neurol 11: 42 – 53.en_US
dc.identifier.citedreferenceTabrizi SJ, Scahill RI, Durr A, Roos RAC, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC, the TRACK‐HD investigators ( 2011 ): Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK‐HD study: The 12‐month longitudinal analysis. Lancet Neurol 10: 31 – 42.en_US
dc.identifier.citedreferenceThompson PM, Hayashi KM, de Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW ( 2004 ): Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 22: 1754 – 1766.en_US
dc.identifier.citedreferenceVaillant M, Glaunès J ( 2005 ): Surface matching via Currents. In: Christensen G, Sonka M, Editors. Information Processing in Medical Imaging. Lecture notes in computer sciences, New York: Springer‐Verlag. pp 381 – 392.en_US
dc.identifier.citedreferencevan den Bogaard SJ, Dumas EM, Ferrarini L, Milles J, van Buchem MA, van der Grond J, Roos RA ( 2011 ): Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy—results from the TRACK‐HD study. J Neurol Sci 307: 60 – 68.en_US
dc.identifier.citedreferenceVandenberghe W, Demaerel P, Dom R, Maes F ( 2009 ): Diffusion‐weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease. J Neurol 256: 109 – 114.en_US
dc.identifier.citedreferenceVonsattel J, Myers R, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr ( 1985 ): Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44: 559.en_US
dc.identifier.citedreferenceVonsattel JPG, Lianski M ( 1997 ): Huntington's disease.In: Esiri MM, Lee VM‐Y, Trojanowski JQ, Editors. The Neuropathology of Dementia, Cambridge University Press, p 219 – 240.en_US
dc.identifier.citedreferenceWang L, Beg M, Ratnanather J, Ceritoglu C, Younes L, Morris J. Miller M ( 2007 ): Large deformation diffeomorphism and momentum based hippocampal shape discrimination in dementia of the Alzheimer type. IEEE T Med Imaging 26: 462 – 470.en_US
dc.identifier.citedreferenceWarby S, Graham R, Hayden M ( 2010 ): Huntington Disease. US National Library of Medicine Bookshelf (online). Available at: http://www.ncbi.nlm.nih.gov/books/NBK1305 (Accessed May 20, 2011).en_US
dc.identifier.citedreferenceWeaver KE, Richards TL, Liang O, Laurino MY, Samil A, Aylward EH ( 2009 ): Longitudinal diffusion tensor imaging in Huntington's Disease. Exp Neurol 216: 525 – 529.en_US
dc.identifier.citedreferenceYeterian E, Pandya D ( 1995 ): Corticostriatal connections of extrastriate visual areas in rhesus monkeys. J Comp Neurol 352: 436 – 457.en_US
dc.identifier.citedreferenceYeterian EH, Van Hoesen GW ( 1978 ): Cortico‐striate projections in the rhesus monkey: The organization of certain cortico‐caudate connections. Brain Res 139: 43 – 63.en_US
dc.identifier.citedreferenceYeterian EH, Pandya DN ( 1993 ): Striatal connections of the parietal association cortices in rhesus monkeys. J Comp Neurol 332: 175 – 197.en_US
dc.identifier.citedreferenceYounes L ( 2010 ): Shapes and Diffeomorphisms. New York: Springer.en_US
dc.identifier.citedreferenceZhang Y, Long JD, Mills JA, Warner JH, Lu W, Paulsen JS; PREDICT‐HD Investigators and Coordinators of the Huntington Study Group ( 2011 ): Indexing disease progression at study entry with individuals at‐risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 156B: 751 – 763.en_US
dc.identifier.citedreferenceZuccato C, Cattaneo E ( 2009 ): Brain‐derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5: 311 – 322.en_US
dc.identifier.citedreferenceAlbin RL, Reiner A, Anderson KD, Dure LSt, Handelin B, Balfour R, Whetsell WO Jr, Penney JB, Young AB ( 1992 ): Preferential loss of striato‐external pallidal projection neurons in presymptomatic Huntington's disease. Ann Neurol 31: 425 – 430.en_US
dc.identifier.citedreferenceAlbin RL, Reiner A, Anderson KD, Penney JB, Young AB ( 1990 ): Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity‐akinesia. Ann Neurol 27: 357 – 365.en_US
dc.identifier.citedreferenceAlbin RL, Young AB, Penney JB ( 1989 ): The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366 – 375.en_US
dc.identifier.citedreferenceAlbin RL, Young AB, Penney JB, Handelin B, Balfour R, Anderson KD, Markel DS, Tourtellotte WW, Reiner A ( 1990 ): Abnormalities of striatal projection neurons and N‐methyl‐D‐aspartate receptors in presymptomatic Huntington's disease. N Engl J Med 322: 1293 – 1298.en_US
dc.identifier.citedreferenceAlexander G, DeLong M, Strick P ( 1986 ): I. Parallel organization of cuntionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9: 357 – 381.en_US
dc.identifier.citedreferenceAshburner J, Csernansky JG, Davatzikos C, Fox NC, Frisoni GB, Thompson PM ( 2003 ): Computer‐assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol 2: 79 – 88.en_US
dc.identifier.citedreferenceAylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, Johnson HJ, Magnotta VA, Juhl AR, Paulsen JS ( 2011 ): Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 82: 405 – 410.en_US
dc.identifier.citedreferenceAylward EH, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, Brandt J, Gourley LM, Liang K, Zhou H, Margolis RL, Ross CA ( 2004 ): Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63: 66 – 72.en_US
dc.identifier.citedreferenceBraak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E ( 2003 ): Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197 – 211.en_US
dc.identifier.citedreferenceBrown TB, Bogush AI, Ehrlich ME ( 2008 ): Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse. Hum Mol Genet 17: 3095 – 3104.en_US
dc.identifier.citedreferenceCavada C, Goldman‐Rakic PS ( 1991 ): Topographic segregation of corticostriatal projections from posterior parietal subdivisions in the macaque monkey. Neuroscience 42: 683 – 696.en_US
dc.identifier.citedreferenceCsernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP, Grenander U, Miller MI ( 1998 ): Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc Natl Acad Sci USA 95: 11406 – 11411.en_US
dc.identifier.citedreferenceCsernansky JG, Wang L, Jones D, Rastogi‐Cruz D, Posener JA, Heydebrand G, Miller JP, Miller MI ( 2002 ): Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. Am J Psychiat 159: 2000 – 2006.en_US
dc.identifier.citedreferenceCsernansky JG, Wang L, Joshi S, Miller JP, Gado M, Kido D, McKeel D, Morris JC, Miller MI ( 2000 ): Early DAT is distinguished from aging by high‐dimensional mapping of the hippocampus. Neurology 55: 1636 – 1643.en_US
dc.identifier.citedreferenceCudkowicz M, Kowall NW ( 1990 ): Degeneration of pyramidal projection neurons in Huntingtons‐disease cortex. Ann Neurol 27: 200 – 204.en_US
dc.identifier.citedreferencede la Monte SM, Vonsattel JP, Richardson EP Jr ( 1988 ): Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 47: 516 – 525.en_US
dc.identifier.citedreferenceDeng Y, Albin R, Penney J, Young A, Anderson K, Reiner A ( 2004 ): Differential loss of striatal projection systems in Huntington's disease: A quantitative immunohistochemical study. J Chem Neuroanat 27: 143 – 164.en_US
dc.identifier.citedreferenceDouaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, Golestani N, Krystkowiak P, Verny C, Damier P, Bachoud‐Levi AC, Hantraye P, Remy P ( 2009 ): In vivo evidence for the selective subcortical degeneration in Huntington's disease. NeuroImage 46: 958 – 966.en_US
dc.identifier.citedreferenceDouaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud‐Levi AC, Hantraye P, Remy P ( 2006 ): Distribution of grey matter atrophy in Huntington's disease patients: A combined ROI‐based and voxel‐based morphometric study. NeuroImage 32: 1562 – 1575.en_US
dc.identifier.citedreferenceFennema‐Notestine C, Archibald SL, Jacobson MW, Corey‐Bloom J, Paulsen JS, Peavy GM, Gamst AC, Hamilton JM, Salmon DP, Jernigan TL ( 2004 ): In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63: 989 – 995.en_US
dc.identifier.citedreferenceFerrante R, Beal MF, Kowall NW, Richardson EP Jr, Martin JB ( 1987a ): Sparing of acetylcholinesterase‐containing striatal neurons in Huntington's disease Brain Res 411: 162 – 166.en_US
dc.identifier.citedreferenceFerrante RJ, Kowall NW, Beal MF, Richardson EP Jr, Bird ED, Martin JB ( 1985 ): Selective sparing of a class of striatal neurons in Huntington's disease. Science 230: 561 – 563.en_US
dc.identifier.citedreferenceFerrante RJ, Kowall NW, Richardson EP Jr, Bird ED, Martin JB ( 1986 ): Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum. Neurosci Lett 71: 283 – 288.en_US
dc.identifier.citedreferenceFerrante RJ, Beal MF, Kowall NW, Richardson EP Jr, Martin JB ( 1987b ): Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 46: 12 – 27.en_US
dc.identifier.citedreferenceGrenander U, Miller MI ( 2007 ): Pattern Theory: From Representation to Inference. New York: Oxford University Press. xii, 596 p.en_US
dc.identifier.citedreferenceGu X, Li C, Wei W, Lo V, Gong S, Li SH, Iwasato T, Itohara S, Li XJ, Mody I, Heintz N, Yang XW ( 2005 ): Pathological cell‐cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46: 433 – 444.en_US
dc.identifier.citedreferenceHaber SN, Knutson B ( 2009 ): The reward circuit: Linking primate anatomy and human imaging. Neuropsychopharmacology 35: 4 – 26.en_US
dc.identifier.citedreferenceHarper P, Lim C, Craufurd D ( 2000 ): Ten years of presymptomatic testing for Huntington's disease: The experience of the UK Huntington's disease Prediction Consortium. J Med Genet 37: 567 – 571.en_US
dc.identifier.citedreferenceHD Collaborative Group ( 1993 ): A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971 – 983.en_US
dc.identifier.citedreferenceHedreen JC, Peyser CE, Folstein SE, Ross CA ( 1991 ): Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 133: 257 – 261.en_US
dc.identifier.citedreferenceHobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI, Barnes J, Fox NC, Tabrizi SJ ( 2010 ): The progression of regional atrophy in premanifest and early Huntington's disease: A longitudinal voxel‐based morphometry study. J Neurol Neurosurg Psychiatry 81: 756 – 763.en_US
dc.identifier.citedreferenceHobbs NZ, Henley SM, Wild EJ, Leung KK, Frost C, Barker RA, Scahill RI, Barnes J, Tabrizi SJ, Fox NC ( 2009 ): Automated quantification of caudate atrophy by local registration of serial MRI: Evaluation and application in Huntington's disease. NeuroImage 47: 1659 – 1665.en_US
dc.identifier.citedreferenceImarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR, Rubinsztein DC ( 2008 ): Huntington's disease: From pathology and genetics to potential therapies. Biochem J 412: 191 – 209.en_US
dc.identifier.citedreferenceJernigan TL, Salmon DP, Butters N, Hesselink JR ( 1991 ): Cerebral Structure on Mri.2. Specific Changes in Alzheimers and Huntingtons Diseases. Biol Psychiat 29: 68 – 81.en_US
dc.identifier.citedreferenceJurgens CK, van de Wiel L, van Es AC, Grimbergen YM, Witjes‐Ane MN, van der Grond J, Middelkoop HA, Roos RA ( 2008 ): Basal ganglia volume and clinical correlates in ‘preclinical’ Huntington's disease. J Neurol 255: 1785 – 1791.en_US
dc.identifier.citedreferenceKemp J, Powell T ( 1970 ): The cortico‐striate projection in the monkey. Brain 93: 525 – 546.en_US
dc.identifier.citedreferenceKunzle H ( 1975 ): Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study inMacaca fascicularis. Brain Res 88: 195 – 209.en_US
dc.identifier.citedreferenceKunzle H ( 1977 ): Projections from the primary somatosensory cortex to basal ganglia and thalamus in the monkey. Exp Brain Res 30: 481 – 492.en_US
dc.identifier.citedreferenceLangbehn DR, Hayden MR, Paulsen JS ( 2010 ): CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet 153B: 397 – 408.en_US
dc.identifier.citedreferenceLange H, Thörner G, Hopf A, Schröder K ( 1976 ): Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci 28: 401 – 425.en_US
dc.identifier.citedreferenceMa J, Miller M, Younes L ( 2010 ): A bayesian generative model for surface template estimation. Int J Biomed Imaging 2010: 14.en_US
dc.identifier.citedreferenceMarrakchi‐Kacem L, Delmaire C, Tucholka A, Roca P, Guevara P, Poupon F, Yelnik J, Durr A, Mangin JF, Lehericy S, Poupon C ( 2010 ): Analysis of the striato‐thalamo‐cortical connectivity on the cortical surface to infer biomarkers of Huntington's disease. Med Image Comput Comput Assist Interv 13: 217 – 224.en_US
dc.identifier.citedreferenceMorrison P, Harding‐Lester S, Bradley A ( 2011 ): Uptake of Huntington disease predictive testing in a complete population. Clin Genet 80: 281 – 286.en_US
dc.identifier.citedreferenceMumford D, Desolneux A ( 2010 ): Pattern Theory: The Stochastic Analysis of Real‐world signals. Natick: A. K. Peters. 375 p.en_US
dc.identifier.citedreferenceNichols T, Hayasaka S ( 2003 ): Controlling the familywise error rate in functional neuroimaging: A comparative review. Stat Methods Med Res 12: 419 – 446.en_US
dc.identifier.citedreferenceNopoulos PC, Aylward EH, Ross CA, Johnson HJ, Magnotta VA, Juhl AR, Pierson RK, Mills J, Langbehn DR, Paulsen JS ( 2010 ): Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis 40: 544 – 554.en_US
dc.identifier.citedreferenceLee JK, Mathews K, Schlaggar B, Perlmutter J, Paulsen JS, Epping E, Burmeister L, Nopoulos P ( 2012 ): Measures of growth in children at risk for Huntington disease. Neurology 79: 668 – 674.en_US
dc.identifier.citedreferenceNopoulos PC, Aylward EH, Ross CA, Mills JA, Langbehn DR, Johnson HJ, Magnotta VA, Pierson RK, Beglinger LJ, Nance MA, Barker RA, Paulsen JS ( 2011 ): Smaller intracranial volume in prodromal Huntington's disease: Evidence for abnormal neurodevelopment. Brain 134: 137 – 42.en_US
dc.identifier.citedreferencePaulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC ( 2006 ): Brain structure in preclinical Huntington's disease. Biol Psychiatry 59: 57 – 63.en_US
dc.identifier.citedreferencePaulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M ( 2008 ): Detection of Huntington's disease decades before diagnosis: The PREDICT‐HD study. J Neurol Neurosurg Psychiatry 79: 874 – 880.en_US
dc.identifier.citedreferencePaulsen JS, Nopoulos PC, Aylward E, Ross CA, Johnson H, Magnotta VA, Juhl A, Pierson RK, Mills J, Langbehn D, Nance M ( 2010 ): Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 82: 201 – 207.en_US
dc.identifier.citedreferencePaulson H, Albin R ( 2010 ): Huntington's disease: Clinical features and routes to therapy. In: Lo D, Hughes R, editors. Neurobiology of Huntington's disease: applications to drug discovery, CRC press, Boca Raton (FL), Chapter 1.en_US
dc.identifier.citedreferencePierson R, Johnson H, Harris G, Keefe H, Paulsen JS, Andreasen NC, Magnotta VA ( 2011 ): Fully automated analysis using BRAINS: AutoWorkup. NeuroImage 54: 328 – 336.en_US
dc.identifier.citedreferenceQiu A, Adler M, Crocetti D, Miller MI, Mostofsky SH ( 2010 ): Basal ganglia shapes predict social, communication, and motor dysfunctions in boys with autism spectrum disorder. J Am Acad Child AdolescPsychiatry 49: 539 – 551.en_US
dc.identifier.citedreferenceQiu A, Crocetti D, Adler M, Mahone EM, Denckla MB, Miller MI, Mostofsky SH ( 2009a ): Basal ganglia volume and shape in children with attention deficit hyperactivity disorder. Am J Psychiatry 166: 74 – 82.en_US
dc.identifier.citedreferenceQiu A, Fennema‐Notestine C, Dale AM, Miller MI ( 2009b ): Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease. NeuroImage 45: 656 – 661.en_US
dc.identifier.citedreferenceQiu A, Wang L, Younes L, Harms MP, Ratnanather JT, Miller MI, Csernansky JG ( 2009c ): Neuroanatomical asymmetry patterns in individuals with schizophrenia and their non‐psychotic siblings. NeuroImage 47: 1221 – 1229.en_US
dc.identifier.citedreferenceQiu A, Younes L, Miller MI, Csernansky JG ( 2008 ): Parallel transport in diffeomorphisms distinguishes the time‐dependent pattern of hippocampal surface deformation due to healthy aging and the dementia of the Alzheimer's type. NeuroImage 40: 68 – 76.en_US
dc.identifier.citedreferenceQiu A, Younes L, Wang L, Ratnanather JT, Gillepsie SK, Kaplan G, Csernansky J, Miller MI ( 2007 ): Combining anatomical manifold information via diffeomorphic metric mappings for studying cortical thinning of the cingulate gyrus in schizophrenia. NeuroImage 37: 821 – 833.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hbm22214.pdf
Size:
1.297MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.